Concord Medical Services NYSE: CCM

Let’s look at the latest quarterly results. Then let’s look at the CEO and COO acquiring shares from other shareholders.

Second Quarter 2013 Highlights

Total net revenue, which consists of net revenues generated from the network business and hospital business, was RMB254.0 million ($41.4 million) in the second quarter of 2013, an 86.1% increase from RMB136.5 million in the second quarter of 2012.
Gross profit in the second quarter of 2013 was RMB105.2 million ($17.1 million), a 12.1% increase from RMB93.9 million in the second quarter of 2012.
Net income attributable to ordinary shareholders in the second quarter of 2013 was RMB29.1 million ($4.7 million), a 21.9% decrease from RMB37.2 million in the second quarter of 2012.
Basic and diluted earnings per American depositary share (“ADS”)[2] in the second quarter of 2013 were both RMB0.65 ($0.11).
Adjusted EBITDA[3] (non-GAAP) in the second quarter of 2013 was RMB104.3 million ($17.0 million), a 11.3% increase from RMB93.7 million in the second quarter of 2012.

Pages: 1 2

Concord Medical Services is included in StockGuru’s 12 BioTech Break-out Stocks